This site is intended for Healthcare professionals only.
×

Sequent Scientific posts Rs 30.53 crore profit for Q2


Sequent Scientific posts Rs 30.53 crore profit for Q2

New Delhi: Drug firm Sequent Scientific reported a consolidated net profit of Rs 30.53 crore for the quarter ending September 30.

The company had posted a net loss of Rs 4.44 crore for the corresponding period of the previous fiscal, Sequent Scientific said in a filing to BSE.

Consolidated total income of the company stood at Rs 271.93 crore for the quarter under consideration as compared to Rs 232.79 crore for the same period previous fiscal.

In a separate filing, the company said its board has declared an interim dividend of Rs 0.20 per equity share of Rs 2 each.

The following two tabs change content below.
Ruby Khatun

Ruby Khatun

Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751


Source: PTI
0 comment(s) on Sequent Scientific posts Rs 30.53 crore profit for Q2

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted